IL177227A0 - Compositions for delivering a hypnotic agent across the oral mucosa - Google Patents

Compositions for delivering a hypnotic agent across the oral mucosa

Info

Publication number
IL177227A0
IL177227A0 IL177227A IL17722706A IL177227A0 IL 177227 A0 IL177227 A0 IL 177227A0 IL 177227 A IL177227 A IL 177227A IL 17722706 A IL17722706 A IL 17722706A IL 177227 A0 IL177227 A0 IL 177227A0
Authority
IL
Israel
Prior art keywords
delivering
compositions
oral mucosa
hypnotic agent
hypnotic
Prior art date
Application number
IL177227A
Other versions
IL177227A (en
Original Assignee
Transcept Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transcept Pharmaceuticals Inc filed Critical Transcept Pharmaceuticals Inc
Publication of IL177227A0 publication Critical patent/IL177227A0/en
Publication of IL177227A publication Critical patent/IL177227A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL177227A 2004-02-17 2006-08-02 Compositions comprising zolpidem for delivering a hypnotic agent across the oral mucosa for treating insomnia IL177227A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78311804A 2004-02-17 2004-02-17
US59862904P 2004-08-03 2004-08-03
PCT/US2005/005021 WO2005079761A1 (en) 2004-02-17 2005-02-16 Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof

Publications (2)

Publication Number Publication Date
IL177227A0 true IL177227A0 (en) 2006-12-10
IL177227A IL177227A (en) 2013-05-30

Family

ID=34890604

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177227A IL177227A (en) 2004-02-17 2006-08-02 Compositions comprising zolpidem for delivering a hypnotic agent across the oral mucosa for treating insomnia

Country Status (7)

Country Link
AU (1) AU2005215782B2 (en)
BR (1) BRPI0507733A (en)
CA (1) CA2556450C (en)
IL (1) IL177227A (en)
MX (1) MXPA06009296A (en)
NZ (1) NZ548856A (en)
WO (1) WO2005079761A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0423800D0 (en) 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
US20070123562A1 (en) * 2005-05-25 2007-05-31 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the-night insomnia
RU2009141168A (en) * 2007-04-09 2011-05-20 Сепракор Инк. (Us) METHODS AND COMPOSITIONS CONTAINING DESENLAFAXIN OR DULOXETINE FOR THE TREATMENT OF RESPIRATORY DYSFUNCTIONS DURING SLEEP
FR2968992B1 (en) * 2010-12-16 2013-02-08 Sanofi Aventis ORODISPERSIBLE PHARMACEUTICAL TABLET BASED ON ZOLPIDEM
CN103919780B (en) * 2012-12-26 2016-12-28 上海中西制药有限公司 Calming soporific preparation, its compound preparation, preparation method and pharmaceutical composition
WO2020075183A1 (en) * 2018-10-08 2020-04-16 Troikaa Pharmaceuticals Limited Oromucosal solutions of zolpidem or pharmaceutically acceptable salts thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW444018B (en) * 1992-12-17 2001-07-01 Pfizer Pyrazolopyrimidines
US6005109A (en) * 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
US6624162B2 (en) * 2001-10-22 2003-09-23 Pfizer Inc. Imidazopyridine compounds as 5-HT4 receptor modulators

Also Published As

Publication number Publication date
CA2556450A1 (en) 2005-09-01
IL177227A (en) 2013-05-30
AU2005215782B2 (en) 2011-04-21
MXPA06009296A (en) 2007-01-26
WO2005079761A1 (en) 2005-09-01
NZ548856A (en) 2009-10-30
BRPI0507733A (en) 2007-07-10
CA2556450C (en) 2013-08-06
AU2005215782A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
IL227117A (en) Insulin-containing pharmaceutical composition formulated for oral delivery
IL173742A0 (en) Compositions for delivering 5-ht agonists across the oral mucosa
EP1715853A4 (en) Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
EP1968554A4 (en) Bioadhesive drug formulations for oral transmucosal delivery
EP1757273A4 (en) Preparation for oral administration
ZA200606229B (en) A pharmaceutical composition
IL182964A0 (en) Gabapentin prodrug sustained release oral dosage forms
ZA200701557B (en) Pharmaceutical compositions comprising diclofenac
PL1973422T3 (en) Compositions providing a heating sensation for oral or dermal delivery
HK1090308A1 (en) Directly compressible pharmaceutical composition for the oral admnistration of cci-779
EP1773376A4 (en) Antidiabetic oral insulin-biguanide combination
IL180350A0 (en) Compositions for delivering highly water soluble drugs
ZA200606174B (en) Multiparticulate formulations for oral delivery
EP1806125A4 (en) Liquid compositions for oral cavity
EP1750677A4 (en) Oral therapeutic compound delivery system
EP1806148A4 (en) Medicinal composition for inhalation
EP1761250A4 (en) Oral delivery system
EP1941896A4 (en) Dipeptide-containing composition for oral administration
SI1814520T1 (en) Pharmaceutical compositions comprising a camtothecin derivate
IL177227A0 (en) Compositions for delivering a hypnotic agent across the oral mucosa
EP1967179A4 (en) Composition for oral use
IL180316A0 (en) Quinolone-containing medicinal composition
GB0423800D0 (en) New pharmaceutical formulations
IL198760A0 (en) Oral formulations
GB0400452D0 (en) A pharmaceutical composition

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees